project #7

n-house Private Fund Portfolio
The above represents the basic allocation:
15,000 USDT → estimated profit 6%
30,000 USDT → estimated profit 8.2%
50,000 USDT → estimated profit 11%
75,000 USDT → estimated profit 13.8%

All of the above represent quarterly returns.

Genomic Revolution The convergence of multiomics tools, AI, and precision medicine is rewriting the healthcare playbook, unlocking new applications in diagnostics, drug discovery, and curative therapies. This shift promises to fundamentally reshape how we approach disease and disease management, offering unprecedented opportunities for early intervention and improved patient outcomes. Genomic Revolution Strategy invests in the technological flywheel driving the future of medicine, seeking to capture the full potential of this transformative shift in healthcare.

TAzvbo3T8d53HcikjWduSVFhRrwCztSL3s